Inventor · disambiguated record
Hong Lin
Also filed as: LIN HONG · LIN HONG-PING
30 granted patents·28 pending applications·60 citations·filing 1997–2024
94Inventor score
Files withPRELUDE THERAPEUTICS INC15IND TECH RES INST6QUANTA THERAPEUTICS INC6GLAXOSMITHKLINE LLC4LIN HONG4
Top patents by PatentIndex Score
58 records- 0194US11254683B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·3 cites·35 claims
- 0294US11214574B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Jan 4, 2022·3 cites·16 claims
- 0391US10570140B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2018·Granted Feb 25, 2020·4 cites·29 claims
- 0490US10711007B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·6 cites·26 claims
- 0587US11912723B2KRAS modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2023·Granted Feb 27, 2024·1 cites·39 claims
- 0685US11208416B2Selective inhibitors of protein arginine methytransterase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Dec 28, 2021·1 cites·37 claims
- 0783US9425000B2Porous carbon material and manufacturing method thereof and supercapacitorIND TECH RES INST·Filed 2012·Granted Aug 23, 2016·7 cites·7 claims
- 0880US10744493B1Method of using biopolymer to synthesize titanium-containing silicon oxide material and applications thereofORIENTAL UNION CHEMICAL CORP·Filed 2019·Granted Aug 18, 2020·2 cites·7 claims
- 0974US12421254B2KRAS modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·17 claims
- 1074US8871234B2UV-resistant gelatin/silica viral particles, preparation method and uses thereofUNIV NAT TAIWAN·Filed 2012·Granted Oct 28, 2014·2 cites·11 claims
- 1173US2022153747A1Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1272US12459950B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·20 claims
- 1372US2025243222A1Pyrimidine based modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1471US12145947B2Pyrimidine based modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2023·Granted Nov 19, 2024·0 cites·22 claims
- 1571US2025042921A1Kras modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1669US11078205B2Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·26 claims
- 1767US2023174539A1Substituted Pyrrolo[2,3-D]Pyrimidines As Inhibitors Of Protein Arginine Methyl Transferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1866US9096605B2Pyrazolopyrimidine derivatives as PI3 kinase inhibitorsLIN HONG·Filed 2012·Granted Aug 4, 2015·1 cites·2 claims
- 1965US10780431B1Method of using biopolymer to synthesize titanium-containing silicon oxide material and applications thereofORIENTAL UNION CHEMICAL CORP·Filed 2019·Granted Sep 22, 2020·0 cites·14 claims
- 2063US9012479B2Pyrazolylaminopyridines as inhibitors of FAKGLAXOSMITHKLINE LLC·Filed 2013·Granted Apr 21, 2015·0 cites·11 claims
- 2163US2024327356A1Pyrimidine based ras modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2261US2011207743A1Pyrazolylaminopyridines as inhibitors of fakADAMS JERRY LEROY·Filed 2009·Application pending·0 cites
- 2361US2010113475A1Pyrazolylaminopyridines as inhibitors of fakADAMS JERRY LEROY·Filed 2009·Application pending·0 cites
- 2460US11524962B2Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2018·Granted Dec 13, 2022·0 cites·23 claims
- 2558US9446034B2Pyrazolylaminopyridines as inhibitors of FAKGLAXOSMITHKLINE LLC·Filed 2015·Granted Sep 20, 2016·0 cites·2 claims
- 2657US10875984B2Inorganic shell, resin composition, and method for making inorganic shellZHEN DING TECH CO LTD·Filed 2017·Granted Dec 29, 2020·0 cites·18 claims
- 2755US5876690AMesoporous aluminosilicate molecular sieves having "tubules-within-a-tubule" hierarchical order morphology and the preparation thereofNAT SCIENCE COUNCIL·Filed 1997·Granted Mar 2, 1999·16 cites·12 claims
- 2854US11633695B1Device and method of simultaneously removing flammable gases and nitrous oxideIND TECH RES INST·Filed 2021·Granted Apr 25, 2023·0 cites·17 claims
- 2954US10695715B2Carbonized material, device for removing ozone, and method for removing ozoneIND TECH RES INST·Filed 2017·Granted Jun 30, 2020·0 cites·10 claims
- 3054US6319486B1Control of morphology of mesoporous aluminosilicate or pure-silica molecular sieves by effect of alcoholCHINESE PETROLEUM CORP·Filed 1999·Granted Nov 20, 2001·14 cites·18 claims
- 3153US2015265589A1Pyrazolylaminopyridines as inhibitors of fakGLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
- 3251US2019214323A1Filler compositions and underfill compositions and molding compounds including the same for preparing semiconductor packagesADVANCED SEMICONDUCTOR ENG·Filed 2019·Application pending·0 cites
- 3349US2022160713A1Selective inhibitor of protein arginine methyltransferase 5 (prmt5)PRELUDE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3449US2022218732A1Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3548US2022152072A1Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3648US2011269774A1Pyrazolylaminopyridines as inhibitors of fakADAMS JERRY·Filed 2011·Application pending·0 cites
- 3746US12440506B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Oct 14, 2025·0 cites·50 claims
- 3845US2006228718A1Method for rapidly identifying bacteria and kit thereofUNIV NAT CHENG KUNG·Filed 2005·Application pending·0 cites
- 3944US10279203B2Composition for preventing or treating dentin-associated symptoms or diseases, and method using the sameSANCASTLE WORLDWIDE CORP·Filed 2018·Granted May 7, 2019·0 cites·17 claims
- 4044US2009137557A1Calcilytic CompoundsKU THOMAS WEN FU·Filed 2006·Application pending·0 cites
- 4144US2011129455A1Inhibitors of akt activityLIN HONG·Filed 2009·Application pending·0 cites
- 4244US2017141007A1Filler compositions and underfill compositions and molding compounds including the same for preparing semiconductor packagesADVANCED SEMICONDUCTOR ENG·Filed 2015·Application pending·0 cites
- 4343US11220524B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2018·Granted Jan 11, 2022·0 cites·20 claims
- 4443US2013258267A1Method for fabricating mesoporous oxide hollow particles and the liquid crystal device comprising the sameINNOLUX CORP·Filed 2013·Application pending·0 cites
- 4543US2014155410A1Pyrazolylaminopyridines as inhibitors of fakGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 4643US2011098221A1INHIBITORS OF Akt ACTIVITYLIN HONG·Filed 2009·Application pending·0 cites
- 4742US10807873B2Method for making multiporous carbon materials by using bio-oilsCPC CORP TAIWAN·Filed 2018·Granted Oct 20, 2020·0 cites·4 claims
- 4842US9901755B2Composition for preventing or treating dentin-associated symptoms or diseases, and method using the sameLIN CHUN PIN·Filed 2011·Granted Feb 27, 2018·0 cites·18 claims
- 4941US2003109377A1Catalyst composition and process for preparing olefin polymersIND TECH RES INST·Filed 2002·Application pending·0 cites
- 5040US2012237748A1Porous carbon material and manufacturing method therofLIN HONG-PING·Filed 2011·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hong Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →